Active substance: methylethylpyridinol
Brief description:the drug has an antihypoxic effect, strengthens the vascular wall, reduces capillary permeability, inhibits platelet aggregation.
Drug indication:
- treatment and prevention of corneal inflammation and burns;
- treatment of hemorrhages in the anterior chamber of the eye;
- treatment and prevention of hemorrhages in the sclera in the elderly;
- thrombosis of the central retinal vein and its branches;
- treatment of myopia complications;
- treatment of myopia complications;
Drug effects: The drug reduces the permeability of capillaries, strengthens the vascular wall, stabilizes the cell membrane, inhibits platelet aggregation, reduces blood clotting and viscosity, has antiaggregational and antihypoxic effects.
Composition: methylethylpyridinol hydrochloride, sodium hyaluronate.
Form of production: 1% eye drops. 5 ml or 10 ml each in a bottle